Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Analysis of HIV-1 clinical trials: statistical magic? The AVANTI Steering Committee.

× No keyword cloud information.

7 in total

Review 1. The role of therapeutic drug monitoring in treatment of HIV infection.

Authors: D J Back; S H Khoo; S E Gibbons; C Merry
Journal: Br J Clin Pharmacol Date: 2001-04 Impact factor: 4.335

2. Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled Trial.

Authors: Sandra A Springer; Angela Di Paola; Russell Barbour; Marwan M Azar; Frederick L Altice
Journal: J Acquir Immune Defic Syndr Date: 2018-09-01 Impact factor: 3.731

Review 3. Amprenavir: a review of its clinical potential in patients with HIV infection.

Authors: S Noble; K L Goa
Journal: Drugs Date: 2000-12 Impact factor: 9.546

4. Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users.

Authors: Frederick L Altice; Sandra Springer; Marta Buitrago; David P Hunt; Gerald H Friedland
Journal: J Urban Health Date: 2003-09 Impact factor: 3.671

5. The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with men.

Authors: Gregory S Zaric; Ahmed M Bayoumi; Margaret L Brandeau; Douglas K Owens
Journal: Med Decis Making Date: 2008-03-18 Impact factor: 2.583

6. Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.

Authors: Sandra A Springer; Angela Di Paola; Marwan M Azar; Russell Barbour; Breanne E Biondi; Maureen Desabrais; Thomas Lincoln; Daniel J Skiest; Frederick L Altice
Journal: J Acquir Immune Defic Syndr Date: 2018-05-01 Impact factor: 3.731

7. Cost-effectiveness of HIV screening in patients older than 55 years of age.

Authors: Gillian D Sanders; Ahmed M Bayoumi; Mark Holodniy; Douglas K Owens
Journal: Ann Intern Med Date: 2008-06-17 Impact factor: 25.391

7 in total